Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · IEX Real-Time Price · USD
40.28
-1.29 (-3.10%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $2.36 billion as of July 26, 2024. Its market cap has increased by 101.89% in one year.
Market Cap
2.36B
Enterprise Value
2.11B
1-Year Change
101.89%
Ranking
Category
Stock Price
$40.28
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $2.36B, an increase of 1,277.55%. That is a compound annual growth rate of 39.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.44B | 84.35% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myriad Genetics | 2.54B |
| Integra LifeSciences Holdings | 2.48B |
| Evolent Health | 2.47B |
| Intellia Therapeutics | 2.47B |
| Certara | 2.47B |
| Beam Therapeutics | 2.45B |
| UFP Technologies | 2.42B |
| Ardent Health Partners | 2.40B |